| P.O.Box 2345, Beijing 100023,China | China Nati J New Gastroenterol 1996 Mar 2;(1):20-21 |
| Email: wcjd@public.bta.net.cn | ISSN 1007-9327 CN 14-1219/ R |
| http:// www.wjgnet.com | Copyright © by The WJG Press |
Alterations
of red blood cell immunoadherence function in hepatitis B patients
Zi-Qin Sun, Yao Jun Wang, Qi Zhen Quan, Rui Ming Xiao, Feng Guo
Subject
headings
hepatitis, viral, human/immunology; erythrocytosis/immunology; autigen-antibody
complex/blood
Sun ZQ, Wang YJ, Quan QZ, Xiao RM, Guo F. Alterations of red blood cell
immunoadherence function in hepatitis B patients. China Nati J New
Gastroenterol,1996;2(1):20-21
Abstract
AIM To investigate the
alterations of RBC immunoadherence function in patients with various hepatitis
B.
METHODS RBCC3bRR, RBCICRR
and serum CIC levels were measured in 42patients with acute and chronic
hepatitis B at active and convalescence stages.
RESULTS
RBCC3bRRs at the active/acute stage of various hepatitis
were decreased. They were 13.54% 5.23%
in AH, 7.61% 4.12% in AFH,and
16.18% 6.10% in CH,
respectively, all of which were lower than those in normal persons(18.12%
3.91%). At the quiescent/recovery stage of various
hepatitis, the RBCC3bRRs were increased
significantly. The changes of RBCICRR and
serum CIC level were contrary to
those of RBCC3bRR.
CONCLUSION RBC
immunoadherence function is decreased in acute and chronic
hepatitis. The decrease is in direct proportion to
the severity of the diseases.
Red blood cell(RBC) has a lot of immunological functions. The most
important one is its
immunoadherence function, to which much attention has been paid in
recent years.In previous studies[1,2], we
observed that RBC immunoad
herence function in rats with acute liver
damage induced by
D-galactosamine was significantly
depressed. In the present study, RBC immunoadherence function was
detected in patients with
acute and chronic hepatitis
B by means of the RBC C3b receptor yeast rosette rate(RBCC3bRR) and the RBC
immune complexes rosette
rate(RBCICRR) test.
PATIENTS and METHODS
Patients
Forty-two patients with acute and chronic hepatitis B
were chosen in the study. The
diagnosis was made according to the diagnostic criteria for hepatitis revised by
the National Viral Hepatitis Conference held in Shanghai in 1990. Among them
were 14 patients with acute
hepatitis(AH, 9 males and 5 females, mean age 39.5
years), 7 patients with acute
fulminent hepatitis(AFH, 5 males and
2 females, mean age 35.4 years), 21
patients with chronic hepatitis(CH,
17 males and 4 females, mean age 36.3
years).All patients
had evidence of HBV infection. The blood specimens were taken from
the patients at the
active(or acute)stage and the convalescent stage. Fifteen cases of blood
donors were chosen as
normal controls(NC, mean age 35.6
years).
Methods
RBCC3bRR test
One mL of heparin-anticoagulated blood specimen was mixed with Fiscol liquor and was
centrifuged to separate red blood cells. The red
blood cells were washedthree times with normal saline and
resuspended in it(1.25 10 cells/ml). Then 0.5ml
of complement-sensitized yeast(1×10/ml)
was added into 0.5 ml of the RBC suspension, which was incubated at 37℃ in a
constant-temperature water bath for 30 min. After being diluted with 1ml of
normal saline, the RBC was fixed by 0.3?ml of
0.25% glutaraldehyde. Alittle of the prepared RBC suspension was smeared
on slide and
stained with Wright's stain. The number of RBC combining with two yeasts
or more was calculated
among 200 RBCs and figured
out the RBCC3bRR.
RBCICRR test
This procedure was the same as the above described
except that the yeast used
was not sensitized by
complement. Circulating immune complexes(CIC) test. Serum
CIC was detected by polythylene
glycol precipitation method.
RESULTS
RBCC3bRR change in various hepatitis
The RBCC3bRRs at the active stage of acute and chronic hepatitis were decreased. The more severe the disease, the lower
the RBCC3bRR.
There was no significant
difference between AH and CH. The
RBCC3bRR was increased gradually when the
patients recovered. Of the 7 patients with AFH, 3 died of acute liver failure.
RBCC3bRRs in the four survivors
were also significantly increased. In CH group,however,
the increase was much slower.
RBCICRR changes in various hepatitis
In various hepatitis, the RBCICRRs were higher than those in normal
controls(in
the order of AFH>CH>AH>NC), which was inversely proportional to
RBCC3bRR changes(r=-0.863, P<0.05).
Serum CIC level
Serum level of immune complexes was
higher in patients with hepatitis than that in
individuals, which was correlated strongly
with RBCICRR changes(r=0.824,
P<0.05), but
negatively with RBCC3bRR changes(r=-0.959, P<0.01).
Table 1
Changes of RBCC3bRR, RBCICRR and serum CIC in various hepatitis
| Group | RBCC3bRR(%) | RBCICRR(%) | Serum CIC(U/L) | |||
| A stage | C stage | A stage | C stage | A stage | C stage | |
| AH | 13.54±5.23 | 17.47±3.82 | 6.46±2.44 | 4.73±2.21 | 470.5±97.3 | 285.3±57.7 |
| AFH | 7.61±4.12 | 15.38±3.55 | 9.10±3.83 | 5.32±1.68 | 534.7±173.8 | 227.1±76.4 |
| CH | 13.96±5.01 | 15.42±5.13 | 7.23±1.94 | 5.78±4.88 | 401.9±137.4 | 357.2±90.1 |
| NC | 18.12±3.91 | 4.61±1.12 | 216.6±34.2 | |||
A=active; C=convalescent
DISCUSSION
The present study demonstrated that RBCC3bRRs in acute and
chronic hepatitis were decreased and the degree of decrease was closely
related to the severity of liver
damage. When the patients were recovered or in quiescent stage, their RBCC3bRR
became elevated. Therefore, RBCC3bRRs can be used to assess the severity and
prognosis of various hepatitis.
It has been verified that there are
type I complement receptors (CR1) on the surface of red blood cells, through
which red blood cells combine with C3b-opsonized
immune complexes,
and bring them to macrophages in liver and
other organs,
and finally are eliminated[3,4].
RBCC3bRR and RBCICRR tests are reliable and
convenient for detecting RBC immunoadherence function[5]. The decrease of RBCC3bRR
suggests that the number of CR1 is
reduced and
its function is diminished. In
a recent in vivo study[1,6],
we observed that red blood
cell immunoadherence function
in acute liver
damage was depressed significantly. The degree of the depression was
strongly related to the increase of hepatic
and serum lipid peroxidate(LPO) level. The in
vitro
study also showed that
LPO could reduce RBCC3bRRs.
Antioxidant therapy with vitamin E could resist the
depression. The reason may be
that LPO can combine with amino acid of CR1 protein,
causing intra- and inter-cross linking, and thus destroy the normal structure
of CR1, which leads
to the decrease of RBC immunoadherence function.
In the present study, we found
that the circulating immune complex wasincreased,
which was related to the decrease of RBCC3bRR. Because CR1 plays an important
role in eliminating CIC,
and about 95% of total C3b receptors
in the circulation are on the RBC surface,
the increase of RBCICRR
reflects in part
the increase of CIC. The mechanism of the decrease of RBC immunoadherence
function may be a complicated one. Further
study will be beneficial to the
prevention
and treatment of hepatitis.
REFERENCES
1
Sun ZQ, Wang YJ, He JW, Guo
F. The dynamic changes
of red blood cell
immunoadherence function and lipid peroxide
in
acute liver failure in rats. Shanghai J Immunol,
1993;13(4): 231-232
2 Sun ZQ, Wang YJ. The coherence
between red blood cell immuno-adherence function and lipid peroxidate in acute
liver
damage. Chin J Exp Clin Immunol, l995;7(1):29-31
3 Siegel I. The red cell immune
system. Lancet, 1981;2(8246):556-557
4 Sun ZQ, Wang YJ. Changes of RBCIA
and its machanism in acute liver damage. Chin J Clin Hepatol,
1993;9(Suppl):65-66
5 Guo F, Yu ZQ, Zhao ZP.
Preliminary study on the immune function of human red cells. Chin J Intern Med,
1982;62(12):715-716
6 Sun ZQ, Wang YJ, Quan QZ, Zhang
ZJ. Dynamic changes of RBC immunoadherent
function and lipid peroxidation and effect
of
vitamin E in acute hepatic injury.
Chin J New Gastroenterol, 1996;4(1):6-8
1Dr. SUN Zi-Qin, Associate Chief Physician, Department of Gastroenterology,General
Hospital of Chinese PLA Jinan Commanding Area, Jinan 250031 Shandong
Province China.
1Dr. WANG
Yao-Jun, Physician-in-Charge.
1Dr.
QUAN Qi-Zhen, Chief physician.
2Dr.
XIAO Rui-Ming, Professor of infectious diseases, Changhai Hospital, Second
Military Medical University,
Shanghai 200433 China.
2Dr. GUO Feng,
Professor of Immunology.
Tel.
+86·531·5952171.
Received
30 October 1995, revised14 November 1995.